Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Infliximab

Various toxicities: 14 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Krstic M, et al. Exploring the Reasons Behind the Substantial Discontinuation Rate Among Patients Taking CT-P13 in a Large Tertiary Hospital in Western Switzerland: A Retrospective Cohort Study Using Routinely Collected Medical Data. Drugs - Real World Outcomes 9 : 425-436, No. 3, Sep 2022. Available from: URL: http://www.springer.com/adis/journal/40801 Krstic M, et al. Exploring the Reasons Behind the Substantial Discontinuation Rate Among Patients Taking CT-P13 in a Large Tertiary Hospital in Western Switzerland: A Retrospective Cohort Study Using Routinely Collected Medical Data. Drugs - Real World Outcomes 9 : 425-436, No. 3, Sep 2022. Available from: URL: http://​www.​springer.​com/​adis/​journal/​40801
Metadaten
Titel
Infliximab
Various toxicities: 14 case reports
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44994-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Aripiprazole

Case report

Aspirin/warfarin

Case report

Sotalol

Case report

Dexamethasone

Case report

Isoniazid

Case report

Arsenic-trioxide